Merck Cdr Stock Performance
| MRK Stock | 27.83 0.87 3.23% |
On a scale of 0 to 100, Merck CDR holds a performance score of 16. The company secures a Beta (Market Risk) of 0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Merck CDR's returns are expected to increase less than the market. However, during the bear market, the loss of holding Merck CDR is expected to be smaller as well. Please check Merck CDR's maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether Merck CDR's current price movements will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Merck CDR are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward-looking signals, Merck CDR displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0267 |
Merck |
Merck CDR Relative Risk vs. Return Landscape
If you would invest 2,281 in Merck CDR on November 30, 2025 and sell it today you would earn a total of 502.00 from holding Merck CDR or generate 22.01% return on investment over 90 days. Merck CDR is generating 0.3335% of daily returns assuming 1.5705% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Merck CDR, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Merck CDR Target Price Odds to finish over Current Price
The tendency of Merck Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 27.83 | 90 days | 27.83 | nearly 4.09 |
Based on a normal probability distribution, the odds of Merck CDR to move above the current price in 90 days from now is nearly 4.09 (This Merck CDR probability density function shows the probability of Merck Stock to fall within a particular range of prices over 90 days) .
Merck CDR Price Density |
| Price |
Predictive Modules for Merck CDR
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Merck CDR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Merck CDR Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Merck CDR is not an exception. The market had few large corrections towards the Merck CDR's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Merck CDR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Merck CDR within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 0.12 | |
σ | Overall volatility | 1.81 | |
Ir | Information ratio | 0.14 |
Merck CDR Fundamentals Growth
Merck Stock prices reflect investors' perceptions of the future prospects and financial health of Merck CDR, and Merck CDR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merck Stock performance.
| Return On Equity | 39.51 | ||||
| Current Valuation | 466.26 B | ||||
| Price To Book | 5.92 X | ||||
| Price To Sales | 4.86 X | ||||
| Revenue | 65.01 B | ||||
| Net Income | 18.25 B | ||||
| Cash And Equivalents | 13.24 B | ||||
| Total Debt | 2.59 B | ||||
| Cash Flow From Operations | 16.47 B | ||||
| Total Asset | 136.87 B | ||||
| Retained Earnings | 73.08 B | ||||
About Merck CDR Performance
By examining Merck CDR's fundamental ratios, stakeholders can obtain critical insights into Merck CDR's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Merck CDR is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Merck CDR is entity of Canada. It is traded as Stock on TO exchange.Things to note about Merck CDR performance evaluation
Checking the ongoing alerts about Merck CDR for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merck CDR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Merck CDR's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Merck CDR's stock performance include:- Analyzing Merck CDR's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merck CDR's stock is overvalued or undervalued compared to its peers.
- Examining Merck CDR's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Merck CDR's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merck CDR's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Merck CDR's stock. These opinions can provide insight into Merck CDR's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Merck Stock
Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.